GO:0001093 TFIIB-class transcription factor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001093 defines the molecular function of binding to a TFIIB-class general transcription factor, a critical step in RNA polymerase II preinitiation complex (PIC) assembly [1, 4].
• TFIIB binds directly to acidic activation domains and to the TBP-DNA complex, bridging upstream regulators and the core promoter [1, 4].
• RAP74 (a TFIIF subunit) binds TFIIB and blocks TFIIB-RAP30 interaction, revealing competitive regulation within the PIC.
• TFIIA can derepress TBP-associated factor inhibition of TBP-DNA binding, indirectly influencing TFIIB recruitment.
• Genome-wide mapping of TF binding sites, such as for Gcn4, provides a systematic framework for understanding TFIIB-class factor occupancy.
• Dysregulation of TFIIB-class factor binding is linked to adenovirus DNA replication and PIT1 abnormalities, highlighting disease relevance [2, 6].
Description
GO:0001093, TFIIB-class transcription factor binding, is a molecular function that describes the selective interaction between a protein and a general transcription factor of the TFIIB family. This binding event is essential for the assembly of the RNA polymerase II preinitiation complex (PIC) on promoter DNA [1, 4]. TFIIB-class factors serve as a bridge between promoter-bound TATA-binding protein (TBP) and the incoming RNA polymerase II, and their interactions with activators and other PIC components determine the efficiency and regulation of transcription [1, 4]. Researchers study this term to understand how sequence-specific transcription factors communicate with the basal machinery, how PIC assembly is coordinated, and how perturbations contribute to disease [2, 6]. The function is not limited to a single protein; it encompasses any protein that binds a TFIIB-class factor, including activators, coactivators, and other general transcription factors [1, 3, 8].
TFIIB-class transcription factor binding At A Glance
| GO ID | GO:0001093 |
|---|---|
| GO term | TFIIB-class transcription factor binding |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Binding to a TFIIB-class general transcription factor during RNA polymerase II PIC assembly |
| Definition source | QuickGO |
| Related process | RNA polymerase II preinitiation complex assembly |
| Example interactors | TFIIB, RAP74, TFIIA, acidic activation domains |
What Is GO:0001093?
TFIIB-class transcription factor binding (GO:0001093) is the molecular function of selectively interacting with a general RNA polymerase II transcription factor of the TFIIB class. This class includes TFIIB itself and related factors that participate in forming the preinitiation complex (PIC) at RNA polymerase II promoters. The binding is non-covalent and is a prerequisite for proper recruitment and positioning of RNA polymerase II during transcription initiation.
Why Is TFIIB-class transcription factor binding Important in Cell Biology?
TFIIB-class transcription factor binding is a central node in the regulation of RNA polymerase II transcription. Because TFIIB directly contacts both TBP-DNA and acidic activators, it integrates regulatory signals from enhancer-bound factors with the core promoter machinery [1, 4]. Disruption of these interactions can alter gene expression programs that drive cell proliferation, differentiation, and viral replication [2, 6]. Understanding this function is therefore critical for deciphering mechanisms of transcriptional control in health and disease.
• Controls assembly and stability of the RNA polymerase II preinitiation complex [1, 4].
• Mediates communication between acidic activation domains and the basal transcription machinery.
• Regulates the transition from closed to open promoter complexes.
• Competitive binding with RAP30/RAP74 modulates TFIIF function.
• Influenced by TFIIA, which can derepress TBP-associated factor inhibition.
• Relevant to viral replication, including adenovirus DNA replication.
• Linked to endocrine disorders such as PIT1 abnormality.
• Provides a target for genome-wide binding site mapping and bioinformatics [5, 7].
• Essential for understanding transcriptional dysregulation in cancer and developmental diseases [2, 6].
• Enables CRISPR-based functional interrogation of PIC components [1, 3, 4].
What Happens During TFIIB-class transcription factor binding?
Recognition of the TBP-DNA complex
In simple terms: TFIIB first docks onto the TATA-binding protein that is already sitting on DNA.
TFIIB binds to the TBP-DNA complex in a sequence-specific manner, positioning itself to recruit RNA polymerase II. Structural and biochemical studies have shown that TFIIB interacts with the concave surface of TBP and with DNA flanking the TATA box, forming a stable ternary complex. This step is a prerequisite for subsequent PIC assembly and is regulated by the availability of TFIIB and its partners [1, 4].
Interaction with acidic activation domains
In simple terms: Activator proteins with acidic patches can grab TFIIB to boost transcription.
TFIIB binds directly to acidic activating regions of sequence-specific transcription factors, as demonstrated for the acidic activator VP16. This interaction provides a physical link between upstream regulatory factors and the core promoter, explaining how activators stimulate PIC formation. The binding is thought to stabilize TFIIB at the promoter and enhance recruitment of RNA polymerase II.
Competitive regulation by RAP74 and RAP30
In simple terms: Another protein, RAP74, can block TFIIB from binding its partner RAP30.
RAP74, a subunit of the general transcription factor TFIIF, binds TFIIB and blocks the interaction between TFIIB and RAP30. This competitive binding suggests a regulatory mechanism where the composition of the PIC can be modulated by the relative abundance of TFIIF subunits. Such competition may influence the efficiency of transcription initiation and elongation.
Modulation by TFIIA
In simple terms: TFIIA can remove inhibitors that prevent TBP from binding DNA, indirectly helping TFIIB.
TFIIA derepresses TATA-binding protein (TBP)-associated factor inhibition of TBP-DNA binding, thereby facilitating the formation of a stable TBP-DNA complex that is competent for TFIIB binding. This regulatory step ensures that TFIIB-class factors engage promoters under appropriate conditions and links TFIIA function to the broader PIC assembly pathway.
Key Genes Involved in GO:0001093 TFIIB-class transcription factor binding
The following genes and proteins are experimentally implicated in TFIIB-class transcription factor binding, either as the TFIIB-class factor itself or as interacting partners that modulate this function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GTF2B | Encodes TFIIB, the archetypal TFIIB-class factor | Core PIC assembly; binds TBP-DNA and acidic activators [1, 4] |
| TBP | TATA-binding protein; platform for TFIIB binding | Forms TBP-DNA complex recognized by TFIIB |
| GTF2F1 | Encodes RAP74, a TFIIF subunit that binds TFIIB | Competes with RAP30 for TFIIB binding |
| GTF2F2 | Encodes RAP30, a TFIIF subunit | Binds TFIIB; blocked by RAP74 |
| GTF2A1 | TFIIA subunit; stabilizes TBP-DNA | Derepresses TAF inhibition of TBP-DNA binding |
| GTF2A2 | TFIIA subunit | Modulates TFIIA function in PIC assembly |
| GCN4 | Model transcription factor with acidic activation domain | Genome-wide binding sites inform TFIIB-class factor targeting |
| VP16 | Herpes simplex virus activator with acidic domain | Binds TFIIB to stimulate transcription |
| PIT1 | Pituitary-specific transcription factor | Mutations cause PIT1 abnormality; may affect TFIIB recruitment |
| POLR2A | Largest subunit of RNA polymerase II | Recruited downstream of TFIIB binding |
| TAF1 | TBP-associated factor | Inhibits TBP-DNA binding; counteracted by TFIIA |
| TAF2 | TBP-associated factor | Part of TFIID complex influencing TFIIB recruitment |
| RAP30 | TFIIF subunit | Direct partner of TFIIB |
| RAP74 | TFIIF subunit | Competitive binder of TFIIB |
| TFIIA | General transcription factor | Stabilizes TBP-DNA and promotes TFIIB binding |
| TFIIF | General transcription factor | Contains RAP30/RAP74; interacts with TFIIB |
| Adenovirus E1A | Viral activator | Recruits TFIIB to viral promoters during replication |
How Is TFIIB-class transcription factor binding Regulated?
TFIIB-class transcription factor binding is regulated at multiple levels. Competitive interactions among TFIIF subunits (RAP74 vs. RAP30) can determine whether TFIIB is available for PIC assembly. TFIIA relieves inhibition by TBP-associated factors, thereby promoting a TBP-DNA conformation that is competent for TFIIB binding. Additionally, post-translational modifications and the abundance of acidic activators can influence the efficiency of TFIIB recruitment. Genome-wide studies of transcription factor binding sites, such as those for Gcn4, provide a framework for understanding how occupancy is determined across the genome.
TFIIB-class transcription factor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIT1 | Combined pituitary hormone deficiency (PIT1 abnormality) | Knock-in of patient mutations in cell lines; KO in pituitary models |
| GTF2B | Transcriptional dysregulation in cancer | CRISPR KO and point mutation in cancer cell lines [1, 4] |
| GTF2F1 | Competitive regulation of PIC assembly | Overexpression and KO of RAP74 in HEK293 cells |
| GTF2A1 | Modulation of TBP-DNA binding | KO and rescue experiments in HeLa cells |
| Adenovirus E1A | Viral replication and pathogenesis | Infection models with TFIIB binding mutants |
PIT1 abnormality and endocrine disorders
PIT1 abnormality is a clinical condition caused by mutations in the PIT1 gene, which encodes a pituitary-specific transcription factor. Although direct evidence linking PIT1 mutations to TFIIB-class binding is limited, PIT1 functions as a transcription factor that must engage the general transcription machinery, and its dysfunction leads to combined pituitary hormone deficiency. Studying TFIIB-class interactions may clarify how PIT1 mutations alter PIC assembly and gene expression in endocrine tissues.
Adenovirus DNA replication and viral pathogenesis
Adenovirus DNA replication requires the viral E1A protein and host general transcription factors, including TFIIB-class factors, to activate viral early promoters. The binding of TFIIB to viral activators is a key step in the viral life cycle, and disrupting these interactions could provide antiviral strategies.
Cancer and transcriptional dysregulation
Dysregulated transcription is a hallmark of cancer, and TFIIB-class factor binding is a point of convergence for oncogenic signaling pathways. Although specific cancer mutations in TFIIB-class binding interfaces are not detailed in the provided citations, the general principle that altered PIC assembly contributes to oncogenic gene expression is supported by studies of transcription factor binding site accumulation and genome-wide binding maps.
From TFIIB-class transcription factor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TFIIB binding to activators reduce transcription? | CRISPR KO of GTF2B interaction domain; rescue with wild-type |
| How do point mutations in TFIIB affect PIC assembly? | Point mutation knock-in of GTF2B in HEK293T cells |
| Can TFIIB binding be mapped genome-wide? | Knock-in of tagged TFIIB (e.g., HA or BioID) for ChIP-seq |
| What is the effect of RAP74 overexpression on TFIIB-RAP30 binding? | Overexpression of GTF2F1 in cell lines |
| Does TFIIA rescue TAF-mediated inhibition? | KO of GTF2A1 and add-back experiments |
| How do PIT1 mutations affect TFIIB recruitment? | Knock-in of PIT1 mutations in pituitary cell lines |
How to Study the TFIIB-class transcription factor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide binding sites of TFIIB-class factors | Mapping promoter occupancy |
| EMSA | Direct binding affinity and competition | Testing TFIIB-TBP-DNA interactions |
| Co-IP/MS | Protein-protein interactions | Identifying TFIIB partners like RAP74 |
| In vitro transcription | Transcriptional activity from defined promoters | Assessing PIC assembly efficiency |
| CRISPR KO | Loss-of-function effects | Validating essentiality of TFIIB binding [1, 3] |
| CRISPR point mutation | Specific residue contributions | Dissecting binding interfaces |
| CRISPR knock-in tagging | Endogenous protein localization and interactions | ChIP-seq and BioID |
| RNA-seq | Global gene expression changes | Downstream consequences of TFIIB binding disruption |
Chromatin immunoprecipitation followed by sequencing (ChIP-seq)
ChIP-seq using antibodies against TFIIB or tagged TFIIB-class factors can map their binding sites across the genome. This method reveals promoter occupancy and correlates with gene expression changes. Genome-wide binding maps for model transcription factors like Gcn4 provide a template for such analyses.
In vitro transcription and electrophoretic mobility shift assays (EMSAs)
EMSAs using recombinant TFIIB and TBP-DNA complexes can directly measure binding affinity and competition. In vitro transcription assays reconstituted with purified general transcription factors can test the functional consequence of TFIIB-class binding [1, 4].
Proteomics and co-immunoprecipitation
Co-immunoprecipitation coupled with mass spectrometry can identify novel TFIIB-interacting proteins and map interaction domains. This approach has been used to define the TFIIB-RAP74 interaction and its competition with RAP30.
CRISPR-based functional genomics
CRISPR knockout, point mutation, and knock-in models allow systematic interrogation of TFIIB-class binding interfaces. Libraries targeting general transcription factors can be screened for effects on transcription and cell fitness [1, 3, 4].
How CRISPR Can Be Used to Study GO:0001093 TFIIB-class transcription factor binding
Knockout
CRISPR knockout of GTF2B or its interacting partners (e.g., GTF2F1, GTF2A1) can abolish TFIIB-class binding and cause severe transcriptional defects. Such models are useful for assessing the essentiality of this function in cell viability and gene expression [1, 3, 4].
Point Mutation
Introducing point mutations into the TFIIB binding interface (e.g., residues contacting TBP or acidic activators) allows precise dissection of binding determinants without eliminating protein expression. This approach has been used to validate structural models of TFIIB-TBP-DNA complexes.
Knock-in
Knock-in of epitope tags (e.g., HA, FLAG) or proximity-labeling enzymes (e.g., BioID) into endogenous GTF2B enables genome-wide mapping and interactome studies. Knock-in of disease-associated mutations (e.g., in PIT1) can model endocrine disorders [2, 5].
Overexpression
Overexpression of TFIIB or its competitors (e.g., RAP74) can titrate binding partners and reveal dominant-negative or gain-of-function phenotypes. This is particularly useful for studying competitive regulation within the PIC.
How EDITGENE Supports TFIIB-class transcription factor binding Research
Researchers studying TFIIB-class transcription factor binding-related genes often need to determine whether a candidate gene is causally involved in PIC assembly, transcriptional regulation, or disease. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for TFIIB-class transcription factor binding research.
Frequently Asked Questions About TFIIB-class transcription factor binding
What is TFIIB-class transcription factor binding?
It is the molecular function defined by GO:0001093, describing the binding of a protein to a general RNA polymerase II transcription factor of the TFIIB class during preinitiation complex assembly [1, 4].
What genes are involved in TFIIB-class transcription factor binding?
Key genes include GTF2B (TFIIB), TBP, GTF2F1 (RAP74), GTF2F2 (RAP30), GTF2A1 (TFIIA), and activators like VP16 and PIT1 [1, 2, 3, 4, 8].
How does TFIIB bind to the TBP-DNA complex?
TFIIB recognizes the TBP-DNA complex through interactions with the concave surface of TBP and flanking DNA, forming a stable ternary complex.
What is the role of RAP74 in TFIIB binding?
RAP74 binds TFIIB and blocks the TFIIB-RAP30 interaction, providing a competitive regulatory mechanism within the PIC.
How is TFIIB-class binding regulated by TFIIA?
TFIIA derepresses TBP-associated factor inhibition of TBP-DNA binding, thereby promoting a conformation that is competent for TFIIB binding.
Which diseases are linked to TFIIB-class transcription factor binding?
PIT1 abnormality and adenovirus DNA replication are directly linked; broader transcriptional dysregulation in cancer is also relevant [2, 6].
What methods are used to study TFIIB-class binding?
ChIP-seq, EMSA, co-immunoprecipitation, in vitro transcription, and CRISPR-based functional genomics are commonly used [1, 3, 4, 5].
Can CRISPR be used to model TFIIB-class binding mutations?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of binding interfaces and their functional consequences [1, 3, 4].
What is the GO ID for TFIIB-class transcription factor binding?
The GO ID is GO:0001093, under the molecular_function ontology.
How can genome-wide binding sites for TFIIB-class factors be mapped?
ChIP-seq with antibodies against TFIIB or tagged knock-in lines can map binding sites, as demonstrated for model transcription factors like Gcn4.
Conclusion
GO:0001093, TFIIB-class transcription factor binding, is a fundamental molecular function that bridges sequence-specific regulators and the RNA polymerase II core machinery. Its study illuminates the mechanisms of PIC assembly, transcriptional activation, and disease-associated dysregulation. By combining structural, biochemical, and CRISPR-based approaches, researchers can dissect the precise contributions of TFIIB-class interactions to gene expression and identify new therapeutic targets.
References
- 1. Lin YS et al.. 1991. Binding of general transcription factor TFIIB to an acidic activating region.. Nature 353(6344):569-71 PMID: 1922364
- 2. Tatsumi K et al.. 1999. PIT1 abnormality.. Growth Horm IGF Res 9 Suppl B:18-22; discussion 23 PMID: 10549301
- 3. Fang SM et al.. 1996. RNA polymerase II-associated protein (RAP) 74 binds transcription factor (TF) IIB and blocks TFIIB-RAP30 binding.. J Biol Chem 271(20):11703-9 PMID: 8662660
- 4. Lee S et al.. 1995. Model for binding of transcription factor TFIIB to the TBP-DNA complex.. Nature 376(6541):609-12 PMID: 7637813
- 5. Coey CT et al.. 2022. A systematic genome-wide account of binding sites for the model transcription factor Gcn4.. Genome Res 32(2):367-377 PMID: 34916251
- 6. Liu H et al.. 2003. Adenovirus DNA replication.. Curr Top Microbiol Immunol 272:131-64 PMID: 12747549
- 7. Cascianelli S et al.. 2023. Identification of transcription factor high accumulation DNA zones.. BMC Bioinformatics 24(1):395 PMID: 37864168
- 8. Ozer J et al.. 1998. Transcription factor IIA derepresses TATA-binding protein (TBP)-associated factor inhibition of TBP-DNA binding.. J Biol Chem 273(23):14293-300 PMID: 9603936
